Your browser doesn't support javascript.
loading
Prescription rate of erythropoietin-stimulating agents is low for patients with renal impairment under non-nephrology care in a tertiary-level academic medical center in Japan.
Okamoto, Naoki; Inaguma, Daijo; Hayashi, Hiroki; Koseki, Akira; Iwamori, Toshiya; Kudo, Michiharu; Yuzawa, Yukio.
Afiliação
  • Okamoto N; Department of Internal Medicine, Fujita Health University Bantane Hospital, 3-6-10 Otobashi, Nakagawa, Nagoya, Aichi, 4548509, Japan.
  • Inaguma D; Department of Internal Medicine, Fujita Health University Bantane Hospital, 3-6-10 Otobashi, Nakagawa, Nagoya, Aichi, 4548509, Japan. daijo@fujita-hu.ac.jp.
  • Hayashi H; Department of Nephrology, Fujita Health University, Toyoake, Japan.
  • Koseki A; IBM Research, Tokyo, Japan.
  • Iwamori T; IBM Research, Tokyo, Japan.
  • Kudo M; IBM Research, Tokyo, Japan.
  • Yuzawa Y; Department of Nephrology, Fujita Health University, Toyoake, Japan.
Clin Exp Nephrol ; 26(7): 678-687, 2022 Jul.
Article em En | MEDLINE | ID: mdl-35230570
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Eritropoetina / Insuficiência Renal / Hematínicos / Anemia / Nefrologia Limite: Humans País como assunto: Asia Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Eritropoetina / Insuficiência Renal / Hematínicos / Anemia / Nefrologia Limite: Humans País como assunto: Asia Idioma: En Ano de publicação: 2022 Tipo de documento: Article